Biogen (BIIB) EV to EBITDA (2009 - 2025)
Biogen's EV to EBITDA came in at 94.53 for Q3 2025, down 32.3% from 139.57 a year earlier and down 48.4% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) EV to EBITDA (2009 - 2025) Analysis & Trends
Over the trailing twelve months to Sep 30, 2025, Biogen reported EV to EBITDA of 50.47, down 57.4% year-over-year; for FY2024, it came in at 74.11.
- Going back by year, EV to EBITDA was 19.09 in FY2022 (+101.5%), 9.47 in FY2021 (+36.7%) and 6.93 in FY2020 (+10.2%).
- The five-year range for quarterly EV to EBITDA is 6.93 (Q4 2020) to 273.55 (Q1 2025).
- The fastest year-over-year change in EV to EBITDA over five years came in Q2 2021 (growth of 280.0%), and the weakest in Q2 2022 (a decline of 59.5%).
- Business Quant data shows BIIB's EV to EBITDA at 183.09 (Q2 2025), 273.55 (Q1 2025) and 74.11 (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biogen | 33.37 Bn | 20.03 Bn | 1.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 94.53 |
| Jun 30, 2025 | 183.09 |
| Mar 31, 2025 | 273.55 |
| Dec 31, 2024 | 74.11 |
| Sep 30, 2024 | 139.57 |
| Jun 30, 2023 | 27.14 |
| Mar 31, 2023 | 17.75 |
| Dec 31, 2022 | 12.28 |
| Sep 30, 2022 | 9.81 |
| Jun 30, 2022 | 7.46 |
| Mar 31, 2022 | 9.01 |
| Dec 31, 2021 | 9.47 |
| Sep 30, 2021 | 16.38 |
| Jun 30, 2021 | 18.43 |
| Mar 31, 2021 | 9.55 |
| Dec 31, 2020 | 6.93 |
| Sep 30, 2020 | 5.80 |
| Jun 30, 2020 | 4.85 |
| Mar 31, 2020 | 6.10 |
| Dec 31, 2019 | 6.29 |
API Access
Biogen EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();